Esophageal cancer overview

Revision as of 20:22, 10 September 2015 by Parminder Dhingra (talk | contribs)
Jump to navigation Jump to search

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer overview

CDC on Esophageal cancer overview

Esophageal cancer overview in the news

Blogs on Esophageal cancer overview

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Esophageal cancer is malignancy of the esophagus. There are various subtypes. Esophageal tumors usually lead to dysphagia (difficulty swallowing), pain and other symptoms, and are diagnosed with biopsy. Small and localized tumors are treated with surgery, and advanced tumors are treated with chemotherapy, radiotherapy or combinations. Prognosis depends on the extent of the disease and other medical problems, but is fairly poor.[1]

Classification

Esophageal cancer may be classified into squamous cell carcinoma or adenocarcinoma based on histology.

Pathology

The pathophysiology of esophageal cancer depends on the histological subtype.

Differential diagnosis

Esophageal cancer must be differentiated from *gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal achalasia, gastritis, gastric ulcer, and stomach cancer.

Epidemiology and Demographics

The majority of esophageal cancer cases are reported in the “Asian belt” area which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.

Risk Factors

Common risk factors in the development of esophageal cancer are tobacco smoking, alcohol, gastroesophageal reflux disease, and Barrett's esophagus.

Prognosis

Esophageal cancer is associated with a 5 year survival rate of 20%.

Staging

According to the American Joint Committee on Cancer, there are 4 stages of esophageal cancer based on the tumor spread.

History and Symptoms

Symptoms of esophageal cancer include dysphagia, odynophagia, weight loss, and hematemesis.

Physical examination

Physical examination of patients with esophageal cancer is usually unremarkable.

Laboratory Findings

There are no diagnostic lab findings associated with esophageal cancer.

CT

CT scan may be diagnostic of esophageal cancer. Findings on CT scan suggestive of esophageal cancer include eccentric or circumferential wall thickening, or peri-esophageal soft tissue and fat stranding.

MRI

There are no MRI scan findings associated with esophageal cancer.

Other Imaging Findings

Other imaging studies for esophageal cancer include barium swallow. Findings on barium swallow suggestive of esophageal cancer include irregular stricture, pre-stricture dilatation with 'hold up', and shouldering of the stricture.

Other Diagnostic Studies

Other diagnostic studies for esophageal cancer include FDG-PET (positron emission tomography) scan and endoscopic ultrasound (EUS).


References

  1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52. PMID 14657432.


Template:WikiDoc Sources